Ejaculatory Hood-Sparing Vaporization of the Prostate and Its Impact on Erectile, Ejaculatory, and Sexual Function

• Published in: Urology (Ridgewood, N.J.) N.J.), 2020-10, Vol.144, p.177-181
• Main Authors: Brant, Aaron, Cho, Ahra, Posada Calderon, Lina, Te, Alexis, Kashanian, James, Chughtai, Bilal
• Format: Article
• Language: English
• Subjects: Aged; Ejaculation - physiology; Humans; Laser Therapy - adverse effects; Laser Therapy - methods; Male; Middle Aged; Organ Sparing Treatments - adverse effects; Organ Sparing Treatments - methods; Penile Erection - physiology; Plasma Gases - therapeutic use; Prospective Studies; Prostate - physiopathology; Prostate - surgery; Prostatectomy - adverse effects; Prostatectomy - methods; Prostatic Hyperplasia - complications; Prostatic Hyperplasia - physiopathology; Prostatic Hyperplasia - surgery; Treatment Outcome
• ISSN: 0090-4295; 1527-9995
• DOI: 10.1016/j.urology.2020.06.072

To assess the impact of ejaculatory hood (EH)-sparing transurethral vaporization of the prostate (TUVP) on sexual function, with a specific focus on erectile and ejaculatory function. We studied 25 patients who underwent EH-sparing Photo Selective Vaporization of the Prostate using the Greenlight Laser or Bipolar Button Plasma Vaporization of the Prostate from August 2016 to March 2018. All patients were sexually active with anterograde ejaculation prior to treatment. Patients completed the Male Sexual Health Questionnaire (MSHQ) and AUA Symptom Score pre- and postoperatively. We compared preprocedure sexual function with postprocedure sexual function at 1- and 3-month intervals. A logistic regression model was used to identify predictors of improvement in sexual function. Twenty-five patients underwent EH-sparing TUVP from August 2016 to March 2018. At 3-months postoperatively, patients had significant improvement in erection score (12 vs 9, P = .04) and erection bother score (5 vs 3.5, P